Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients

PURPOSE OF REVIEW: The role of renin-angiotensin-aldosterone system (RAAS) inhibitors, notably angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs), in the COVID-19 pandemic has not been fully evaluated. With an increasing number of COVID-19 cases worldwide, it is...

Descripción completa

Detalles Bibliográficos
Autores principales: Baral, Ranu, White, Madeline, Vassiliou, Vassilios S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443394/
https://www.ncbi.nlm.nih.gov/pubmed/32830286
http://dx.doi.org/10.1007/s11883-020-00880-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443394/
https://www.ncbi.nlm.nih.gov/pubmed/32830286
http://dx.doi.org/10.1007/s11883-020-00880-6

Ejemplares similares